Protect Pharmaceutical Corporation
PRTT
$1.24
-$0.06-4.62%
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -99.30% | -- | -100.00% | -- | 852.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -99.30% | -- | -100.00% | -- | 852.38% |
| Operating Income | 99.30% | -- | 100.00% | -- | -852.38% |
| Income Before Tax | 95.61% | 75.97% | 79.47% | 64.71% | -855.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 95.61% | 75.97% | 79.47% | 64.71% | -855.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 95.61% | 75.97% | 79.47% | 64.71% | -855.24% |
| EBIT | 99.30% | -- | 100.00% | -- | -852.38% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 95.57% | 75.54% | 79.53% | 64.94% | -860.64% |
| Normalized Basic EPS | 95.57% | 75.86% | 79.44% | 64.58% | -855.93% |
| EPS Diluted | 95.57% | 75.54% | 82.50% | 73.00% | -860.64% |
| Normalized Diluted EPS | 95.57% | 80.46% | 79.44% | 68.75% | -855.93% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 22.21% | 0.00% | 11.10% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
